Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Digital Ally awarded government contract for $12.12M for body camerasDigital Ally has been awarded new government contract valued at $12.12M for body cameras, according to the U.S. government. According to a statement, all federal government agencies may place orders against the contract
Read more at:
https://thefly.com/landingPageNews.php?id=3126758
Smart,
Do you know why Gene isn't showing up on the IHub's top list. I didn't see JRJ$C listed also this morning in pre-market.
TIA
Don't forget about the April 13th news:
April 13, 2020
Received $2.4 Million in Purchase Orders and Commitments Over the Past Month Since the Initial Outbreak of COVID-19 in the U.S.
Trading like a $1.00+ stock.
Over $1,000,000 dollars traded so far today. Definitely going way higher. Follow the money.
Good morning Dino,
On Ihub New top lists premarket movers, JRJC isn't showing in the most active or gainers by percentage - could you tell me why?
But you're saying news?
Average daily volume under 200,000, volume almost 7,000,000 today
Somebody knows something and buying shares before the a.m.
Tomorrow should be interesting
Yahoo finance has outstanding shares at 80m
AYRO:
Both splits are complete:
The business combination of Dropcar, Inc. (DCAR) and AYRO, Inc. is expected to be completed today, Thursday, May 28, 2020. As a result, the common stock of DropCar, Inc. will undergo a one-for-ten (1-10) reverse stock split immediately followed by a two-for-one (2-1) forward split. The combined split actions will result in a net effect of a one-for-five (1-5) reverse stock split. DropCar Inc. will also effect a name, symbol, and CUSIP change. The combined company will be named AYRO, Inc. (AYRO).
PF*E on local news this morning. Vaccine may be available in spring 2021. Vaccine doubles your antibodies against Covid versus if you actually contracted Covid and developed antibodies
Appears so
U.S. Stocks Fall as Coronavirus Infections Surge
June 24 2020 - 11:18AM
Dow Jones News
? Print
By Joe Wallace
Stocks tumbled Wednesday as pockets of coronavirus infections emerged in several states, adding to concerns about a second wave of cases that could lead to renewed restrictions on business activity.
The Dow Jones Industrial Average fell 501 points, or 1.9%, to 25655. The S&P 500 declined 1.7%, and the Nasdaq Composite lost 1.4%.
New coronavirus cases have jumped in several states, with Arizona, Texas and California reporting daily records of infections Tuesday. Texas Gov. Greg Abbott and Florida Gov. Ron DeSantis said they would step up enforcement of social-distancing guidelines. California Gov. Gavin Newsom said earlier this week that the surge in cases could force the state to implement stricter measures on businesses and social gatherings once again.
"If this does get worse and more endemic, they will have to lock down some of these states again," said Charles Hepworth, an investment director at GAM Holding. That could lead to another drop off in economic activity, threatening the stock market's nascent recovery.
Carnival shares lost 9.1% Wednesday after S&P downgraded the company's credit rating, saying the cruise industry faced a long period of weak demand. Shares of other cruise operators also declined, with Norwegian Cruise Line falling 10%.
Investors' concerns about the rise in infections have in recent weeks been tempered by optimism about stimulus measures from central banks and major governments, reflected in the rally in most major stock markets.
ATIF -
6/23-ATIF Holdings Limited Announces a One Million Dollar Consulting Service Agreement with Heilongjiang WKG Advertising Co., Ltd
6/8-ATIF Holdings Limited Announces a One Million Dollar Consulting Service Agreement with Shenzhen Agrecoe Biotechnology Co., Lt...
6/11 -ATIF Holdings Limited Announces An Additional US$800,000 Consulting Service Agreement with Yinfu Gold Corporation Brings
4/28 -ATIF Holdings Limited Enters Into US$2.3 million In Contracts to Launch Live Streaming and Short Video Production
4/22 -ATIF Holdings Limited Announces a One Million Dollar Consulting Service Agreement with Caiz Optronics Corp
Spot on!
What would the pps be with a 3 billion valuation?
Very interesting!
"A well-sourced fashion business publication, WWD.com, reported last week that Amazon had boots on the ground at Penney’s headquarters in Plano. Neither company has commented on the rumor. The report quoted a source: “There is an Amazon team in Plano as we speak. There is a dialogue, and I’m told it has a lot to do with Amazon eager to expand its apparel business — for sure.”
Total residual shareholders assets = $4.46B
Total unsecured obligation = $1.318B (Docket 25, page 38)
Value of NOLs @ 30% tax rate on $2.2B = $0.66B
Thus net residual shareholder equity in the current JC Penney holding = $3.802B
i.e. $11.85 / share. *
* Note that the asset valuations are from 2016 and should have at-least 10 ~ 15% additional valuations than what’s on the books (if not more).
10) The facts are just the facts. Bottom of page 14. Period!
https://img1.wsimg.com/blobby/go/e52e137b-92af-4273-a367-58417f136f9d/downloads/Shareholders_Objection_Petition_Docket_Final.pdf?ver=1591920095315
Posted by:Diddy28
Post#17638
Very interesting though
“According to one unnamed source, Amazon already has a “team in Plano (TX),” where Penney is headquartered. Why Amazon might be interested in Penney remains unclear, although three potential factors have been raised in the reporting including the e-tailing and tech giant looking to:
Grow its apparel and accessories sales;
Turn some of the department store’s properties into distribution facilities; and/or
Create “a new tech-driven” store model that would make use of its Just Walk Out cashier-free system.”
Over a hundred thousand has poured in, in a matter of seconds.
$8.5 billion #Coronavirus emergency bill Congressional leaders still plan to pass an emergency package by the end of this week, with funding levels much closer to the $8.5 billion
https://www.washingtonpost.com/us-policy/2020/03/02/congress-coronavirus-emergency-spending/
Posted by: AugustaFriends Member Level Wednesday, 03/04/20 07:21:54 AM
42% is significant
Outstanding!
6 dead in King County, Washington
You can easily access the list from the World Health Organization web site
“The White House did not say which pharmaceutical makers would be at the Monday afternoon meeting”
Looks like it!
TNXP:
Drug developed by UAB and NIH researchers being used to treat Coronavirus patients
The drug Remdesivir is now being used to treat certain coronavirus patients in China. Researchers developed the investigational drug at UAB's Antiviral Drug Discovery and Development Center. (Source: WBRC)
By Joshua Gauntt | February 27, 2020 at 10:47 PM CST - Updated February 28 at 4:09 PM
BIRMINGHAM, Ala. (WBRC) - The drug Remdesivir is now being used to treat certain coronavirus patients in China. Researchers developed the investigational drug at UAB’s Antiviral Drug Discovery and Development Center.
"Those studies are what we call placebo controlled. So some patients get drugged and then other patients just get an inactive medication,” Dr. Whitley, a distinguished professor at UAB and principal investigator of the U19 grant said.
UAB was recently awarded a nearly $40 million, five-year-grant to study and develop treatment for emerging infections like coronaviruses that can cause SARS, MERS and the COVID-19 which is the new strain that caused the outbreak in China.
Dr. Whitley tells us studies are also beginning in the U.S. Early results from the drug being used in China should be back sometime in April. Whitley says if it’s successful and safe for people to take then full production could begin.
"If it is, then we’ll have a theoretical solution to disease in the United States. It will be a question of producing enough drug so if Americans have disease at the frequency that they did in China or now south Korea or Italy, we’ll have enough drug for all Americans,” Whitley added.
This drug could eventually be used to help fight the flu. UAB is also working on a coronavirus vaccine, but doctors say that won’t be available for about a year.
Drug developed by UAB and NIH researchers being used to treat Coronavirus patients
The drug Remdesivir is now being used to treat certain coronavirus patients in China. Researchers developed the investigational drug at UAB's Antiviral Drug Discovery and Development Center. (Source: WBRC)
By Joshua Gauntt | February 27, 2020 at 10:47 PM CST - Updated February 28 at 4:09 PM
BIRMINGHAM, Ala. (WBRC) - The drug Remdesivir is now being used to treat certain coronavirus patients in China. Researchers developed the investigational drug at UAB’s Antiviral Drug Discovery and Development Center.
"Those studies are what we call placebo controlled. So some patients get drugged and then other patients just get an inactive medication,” Dr. Whitley, a distinguished professor at UAB and principal investigator of the U19 grant said.
UAB was recently awarded a nearly $40 million, five-year-grant to study and develop treatment for emerging infections like coronaviruses that can cause SARS, MERS and the COVID-19 which is the new strain that caused the outbreak in China.
Dr. Whitley tells us studies are also beginning in the U.S. Early results from the drug being used in China should be back sometime in April. Whitley says if it’s successful and safe for people to take then full production could begin.
"If it is, then we’ll have a theoretical solution to disease in the United States. It will be a question of producing enough drug so if Americans have disease at the frequency that they did in China or now south Korea or Italy, we’ll have enough drug for all Americans,” Whitley added.
This drug could eventually be used to help fight the flu. UAB is also working on a coronavirus vaccine, but doctors say that won’t be available for about a year.
Agreed
dcsteve posted it on the ibio board
page 2, line 7
HUGE!
“As such, no matter who creates the first COVID-19 vaccine, IBIO stands to benefit greatly. First and foremost, the little guys in the race simply don’t have the production capabilities that are required to produce this vaccine. Moreover, the big guys in the race don’t want to give up their valuable production lines to combat the pandemic, losing money via opportunity cost in the process. So, it doesn’t matter which one of them creates the vaccine first, they are going to be looking for manufacturing facilities that can meet demand quickly and keep up thereafter, the FastPharming Facility is one of very few that can do this.”
You think? Half billion?